Atlas Trials

Novartis Gene Therapies

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Novartis Gene Therapies

RecordFirmDate
Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi (NCT04042025)Novartis Gene Therapies2020-02-10
Single-Dose Gene Replacement Therapy Using for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies (NCT03837184)Novartis Gene Therapies2019-05-31
Single-Dose Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 (NCT03461289)Novartis Gene Therapies2018-08-16
Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2 (NCT03505099)Novartis Gene Therapies2018-04-02
Study of Intrathecal Administration of Onasemnogene Abeparvovec-xioi for Spinal Muscular Atrophy (NCT03381729)Novartis Gene Therapies2017-12-14
Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 (NCT03306277)Novartis Gene Therapies2017-10-24
Long-Term Follow-up Study for Patients From AVXS-101-CL-101 (NCT03421977)Novartis Gene Therapies2017-09-21

Track Novartis Gene Therapies automatically

Every clearance here is in the API, with alerts when new ones post.